Dokumentdetails
ID

oai:pubmedcentral.nih.gov:8629...

Thema
Regular Issue Articles
Autor
Wijeyekoon, Ruwani S. Moore, Sarah F. Farrell, Krista Breen, David P. Barker, Roger A. Williams‐Gray, Caroline H.
Langue
en
Editor

John Wiley & Sons, Inc.

Kategorie

Wiley-Blackwell Online Open

Jahr

2020

Auflistungsdatum

01.12.2023

Schlüsselwörter
parkinson cytokines tau plasma csf pd
Metrisch

Zusammenfassung

INTRODUCTION: Immune markers are altered in Parkinson's disease (PD), but relationships between cerebrospinal fluid (CSF) and plasma cytokines and associations with neurodegeneration‐associated proteins remain unclear.

METHODS: CSF and plasma samples and demographic/clinical measures were obtained from 35 PD patients.

CSF samples were analyzed for cytokines (together with plasma) and for α‐synuclein, amyloid β(1‐42) peptide, total tau, and phospho(Thr231)‐tau.

RESULTS: There were no CSF–plasma cytokine correlations.

Interleukin (IL)‐8 was higher and interferon‐γ, IL‐10, and tumor necrosis factor–α were lower in CSF versus plasma.

In CSF, total tau correlated positively with IL‐8 and IL‐1β, whereas α‐synuclein correlated positively with amyloid β(1‐42) and negatively with semantic fluency (a known marker of PD dementia risk).

DISCUSSION: CSF and peripheral cytokine profiles in PD are not closely related.

Associations between CSF IL‐8 and IL‐1β and tau suggest that CSF inflammatory changes may relate to tau pathology within PD.

CSF α‐synuclein/amyloid β may reflect the risk of developing PD dementia.

© 2020 The Authors.

Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

Wijeyekoon, Ruwani S.,Moore, Sarah F.,Farrell, Krista,Breen, David P.,Barker, Roger A.,Williams‐Gray, Caroline H., 2020, Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease, John Wiley & Sons, Inc.

Dokumentieren

Öffnen Öffnen

Teilen

Quelle

Artikel empfohlen von ES/IODE AI

Use of ileostomy versus colostomy as a bridge to surgery in left-sided obstructive colon cancer: retrospective cohort study
deviating 0 versus surgery bridge colon study left-sided obstructive stoma colostomy cancer cent